Skip to main content
Knight Therapeutics Inc. logo

Knight Therapeutics Inc. — Investor Relations & Filings

Ticker · GUD ISIN · CA4990531069 LEI · 549300LNW93V3HRS7610 TSX Wholesale and retail trade
Filings indexed 598 across all filing types
Latest filing 2026-03-27 Regulatory Filings
Country CA Canada
Listing TSX GUD

About Knight Therapeutics Inc.

https://knighttx.com/

Knight Therapeutics Inc. is a specialty pharmaceutical company dedicated to the acquisition, in-licensing, out-licensing, marketing, and commercialization of innovative pharmaceutical products. The portfolio includes prescription drugs, over-the-counter medications, and biosimilars. Knight operates as a Pan-American (ex-US) entity, concentrating its commercial efforts on Canada and Latin America to deliver both innovative and branded generic products to these specific markets.

Recent filings

Filing Released Lang Actions
Annual report - French.pdf
Regulatory Filings
2026-03-27 English
Annual information form - French.pdf
Regulatory Filings
2026-03-27 English
Audited annual financial statements – French.pdf
Regulatory Filings
2026-03-27 English
Annual report - English.pdf
Regulatory Filings
2026-03-25 English
News release (section 4.8 of NI 62-104) – English.pdf
Regulatory Filings
2026-03-23 English
52-109F1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2026-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.